Ledger.Open graph →
SEC Form D · filed October 22, 2018

RedShift BioAnalytics, Inc

Offering
$10.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
BURLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Bryson Holliman · Burlington, MADirectorWilliam Cadogan · Burlington, MADirectorCharles Marshall · Burlington, MAExec · DirectorEugene Ma · Burlington, MAExecFrank Smith · Burlington, MADirectorPaul Tardif · Burlington, MADirectorCarl C. Riedy · Washington, Washington, D.C.Exec · DirectorCatherine A. Cawthon · Dublin, OHDirectorKathleen A. Pecard · Brookfield, WIDirectorStephen W. Farr · San Ramon, CADirectorChristopher C. Cox · Lansing, MIExecKeith W. Bank · San Ramon, CADirectorFelix D. Navarro-Grau Hurtado · Vancouver, British Columbia, CanadaExecJoshua Pierce · San Francisco, CADirectorKimberly A. Arntson · Vancouver, British Columbia, CanadaExec · DirectorDaniel B. Stein · Fayetteville, ARDirectorPaul Tardif · Burlington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗